Curcumin-Mediated Antimicrobial Photodynamic Therapy Combined with Fluconazole against Candida albicans and Fluconazole-Resistant Candida auris
Rising rates of azole resistance among Candida species, and the emergence of the multidrug-resistant pathogen Candida auris, have renewed interest in non-antibiotic antifungal strategies such as antimicrobial photodynamic therapy (aPDT). We evaluated curcumin, a natural polyphenolic photosensitizer, as an aPDT agent against Candida albicans (ATCC 14053) and C. auris (DSM 21092), and tested whether sub-lethal aPDT could enhance the activity of fluconazole against a confirmed fluconazole-resistant strain. Curcumin (1, 5, or 10 µM) combined with blue-light doses of 5, 10, or 15 J/cm² was tested in triplicate against planktonic cells of both species. One-way ANOVA and pairwise comparisons against untreated controls showed statistically significant, dose-dependent reductions in viable count for nearly every curcumin/light-dose combination (P
Authors
- Burçin Karabey (ORCID: https://orcid.org/0000-0003-4834-6740)
Institutions
- İzmir Kavram Meslek Yüksekokulu (TR)
Publication Details
- Journal
- Black Sea Journal of Engineering and Science
- Published
- 2026-11-15
- DOI
- https://doi.org/10.34248/bsengineering.2011984
- Primary Topic
- Photodynamic Therapy Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00